Marsh & McLennan Q4 Earnings Exceed Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 29 2026
0mins
Should l Buy MRSH?
Source: seekingalpha
- Strong Earnings Performance: Marsh & McLennan reported a Q4 non-GAAP EPS of $2.12, beating expectations by $0.15, which underscores the company's robust profitability and boosts investor confidence.
- Significant Revenue Growth: The company achieved $6.6 billion in revenue for Q4, reflecting an 8.2% year-over-year increase and surpassing market expectations by $50 million, indicating sustained momentum in its insurance and consulting sectors.
- Positive Market Reaction: Analysts generally view Marsh & McLennan's stock as oversold, recommending investors to buy at current price levels, reflecting optimism about the company's long-term growth potential.
- Ticker Change Announcement: The company's ticker symbol will change to MRSH effective January 14, aimed at enhancing brand recognition and attracting more investor attention, potentially driving stock price appreciation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MRSH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MRSH
Wall Street analysts forecast MRSH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRSH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 187.510
Low
Averages
High
Current: 187.510
Low
Averages
High
About MRSH
Marsh & McLennan Companies, Inc. is a professional services company in the areas of risk, strategy and people. The Company conducts business through two segments: Risk and Insurance Services, and Consulting. Risk and Insurance Services segment includes risk management activities (risk advice, risk transfer and risk control and mitigation solutions) as well as insurance and reinsurance broking and services. It conducts business in this segment through Marsh and Guy Carpenter. Marsh is an insurance broker and risk advisor, serving companies, institutions and individuals. Guy Carpenter is a reinsurance intermediary and advisor. Consulting segment includes health, wealth and career advice, solutions and products, and specialized management, strategic, economic and brand consulting services. It conducts business in this segment through Mercer and Oliver Wyman Group. Oliver Wyman Group serves as a critical strategic, economic and brand advisor to private sector and governmental clients.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Acquisition Details: Marsh McLennan Agency has acquired Robinson & Son, a New York-based insurance agency specializing in the maritime industry, although the financial terms remain undisclosed, this move is expected to strengthen Marsh's market position in maritime insurance.
- Employee Integration: All employees of Robinson & Son, including co-founder and agency principal James Robinson, will join Marsh McLennan Agency, which not only helps retain key talent but also promotes business integration and synergy.
- Market Expansion: This acquisition will enable Marsh McLennan Agency to further extend its influence in the maritime insurance market, likely enhancing its customer base and service capabilities in related industries.
- Strategic Implications: By acquiring Robinson & Son, Marsh McLennan Agency demonstrates its growth strategy in the insurance sector, aiming to achieve long-term sustainable development through enhanced expertise and market coverage.
See More
- Strong Earnings Performance: Marsh & McLennan reported a Q4 non-GAAP EPS of $2.12, beating expectations by $0.15, which underscores the company's robust profitability and boosts investor confidence.
- Significant Revenue Growth: The company achieved $6.6 billion in revenue for Q4, reflecting an 8.2% year-over-year increase and surpassing market expectations by $50 million, indicating sustained momentum in its insurance and consulting sectors.
- Positive Market Reaction: Analysts generally view Marsh & McLennan's stock as oversold, recommending investors to buy at current price levels, reflecting optimism about the company's long-term growth potential.
- Ticker Change Announcement: The company's ticker symbol will change to MRSH effective January 14, aimed at enhancing brand recognition and attracting more investor attention, potentially driving stock price appreciation.
See More
- Earnings Release Date: Marsh & McLennan is set to announce its Q4 earnings on January 29 before market open, with a consensus EPS estimate of $1.97, reflecting a 5.3% year-over-year increase, which could further solidify its stable performance in the industry.
- Revenue Expectations: The company anticipates Q4 revenue of $6.55 billion, up 7.4% year-over-year, although revenue estimates have seen six downward revisions in the past three months, indicating cautious market sentiment regarding its long-term growth.
- Historical Performance Review: Over the last two years, Marsh & McLennan has exceeded EPS estimates 100% of the time and revenue estimates 63% of the time, showcasing its consistent strength in profitability and operational efficiency.
- Estimation Revision Dynamics: While EPS estimates have undergone five upward revisions and six downward revisions in the past three months, revenue estimates have seen no upward revisions and six downward adjustments, reflecting a cautious outlook from the market on the company's future performance.
See More

Market Performance: Stocks ended the week mostly unchanged after experiencing significant volatility, with the S&P 500 index dropping 2.1% on Tuesday, marking its largest decline since October.
Political Influence: The decline was triggered by President Trump's threats of tariffs on European countries related to his controversial interest in acquiring Greenland from Denmark.
Recovery Efforts: Following the initial drop, the stock market managed to recover most of its losses later in the week.
Trump's Remarks: The recovery was aided by Trump's speech at the World Economic Forum in Davos, where he softened his stance on the tariff threats.
See More
- Market Performance: The S&P 500 index barely rose 0.03% this week but fell 0.4% overall, indicating investors' insufficient capacity to digest geopolitical news, leaving market sentiment unsettled.
- Natural Gas Surge: Natural gas futures spiked 75% over five trading days due to Winter Storm Fern, reflecting the impact of extreme weather on energy demand and potentially raising profit expectations for related companies.
- Dollar Depreciation Trend: Over the past five days, the EUR/USD rose nearly 2%, while the dollar fell over 2.7% against the Swiss franc, indicating a shift in investor sentiment away from the dollar, which may affect future forex market dynamics.
- Fed Policy Expectations: The market widely anticipates that the Federal Reserve will maintain interest rates in the 3.5%-3.75% range at next week's meeting, with investors closely watching Trump's nomination for the new Fed chair, which could influence future monetary policy direction.
See More

- Rising Demand for Financial Independence: The Oliver Wyman study reveals that the need for financial independence has surged to 41% from 32% in 2022, indicating increasing economic pressure and signaling businesses to adapt their strategies accordingly.
- Increased Wellness Awareness: The proportion of individuals engaging in at least four wellness activities has risen from 22% to 30% since 2021, yet self-reported mental health sentiment has dropped by 7 points, highlighting the need for companies to address employee mental well-being amidst rising health consciousness.
- AI's Role in Health Consultations: Over half of respondents (55%) now rely on AI for everyday health inquiries, with 47% using it for specific conditions and 37% for urgent needs, suggesting that businesses should integrate AI into their services to enhance health management.
- Fragile Consumer Loyalty: While 33% of consumers feel brands are better meeting their needs, 64% indicate they would abandon a brand after a single poor experience, rising to 69% among high-income shoppers, emphasizing the necessity for businesses to improve customer experience to maintain loyalty.
See More







